January 2, 2009 - The Society of Chest Pain Centers designated Texas Health Arlington Memorial Hospital yesterday as a ...
January 2, 2009 - Jennifer Mieres, M.D., associate professor of medicine and director of nuclear cardiology (ASNC) at ...
January 2, 2009 - An Italian study recently found dark chocolate, in moderation, may help prevent cardiovascular disease ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
December 31, 2008 – According to results from a Phase 2 clinical study (BP-23), Zemiva, when combined with the standard of care for the diagnostic evaluation of the chest pain patient, improved sensitivity for the detection of cardiac ischemia by more than 50 percent (p
December 31, 2008 - The FDA today approved Vasovist Injection (gadofosveset trisodium), manufactured by EPIX Pharmaceuticals, is reportedly the first contrast imaging agent for use in patients undergoing magnetic resonance angiography (MRA).
December 30, 2008 - Sapheneia, a global, ISO-certified imaging services company specializing in diagnostic and analytical image processing solutions, signed an agreement with Karolinska University Hospital in Stockholm, Sweden, allowing Karolinska University Hospital to use and evaluate the Sapheneia Clarity CT Solution to lower radiation dose exposure to patients during diagnostic image studies.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
December 31, 2008 - ZOLL Medical Corp. said today Provena St. Joseph Hospital in Elgin, IL implemented the company’s ...
December 30, 2008 - Volcano Corp. will acquire Axsun Technologies Inc., a developer and manufacturer of lasers and optical engines used in medical Optical Coherence Tomography (OCT) imaging systems and advanced photonic components, as part of Volcano’s strategy to establish its position in invasive imaging.
December 30, 2008 - Merit Medical Systems Inc., a manufacturer of disposable devices used in cardiology and radiology procedures, today announced four developments regarding products and approvals.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 29, 2008 – When Zemiva, an imaging agent by Molecular Insight Pharmaceuticals Inc., is combined with the standard of care for the diagnostic evaluation of the chest pain patient, improved the detection of cardiac ischemia by more than 50 percent greater than the standard of care when compared to the standard of care alone.
December 29, 2008 - Edwards Lifesciences Corp. said last week it will voluntarily disclose financial relationships with ...
December 29, 2008 - Calgary Scientific Inc. plans to release its ResolutionMD Cardiac advanced visualization suite of ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
December 23, 2008 – The FDA approved for marketing EPIX Pharmaceuticals’ novel blood pool magnetic resonance angiography (MRA) agent, Vasovist (gadofosveset trisodium), to evaluate aortoiliac occlusive disease (AIOD) in adults with known or suspected peripheral vascular disease.
December 23, 2008 - St. Jude Medical Inc. said this week it completed the acquisition of Radi Medical Systems AB for $250 million in cash.
December 23, 2008 - St. Jude Medical Inc. and MediGuide Inc. today signed a definitive merger agreement where MediGuide will become part of the St. Jude Medical Atrial Fibrillation Division.